Purchases and Sales Made in Q1 2023 in Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME) during Q1 2023. The information is specifically focused on institutions that hold shares of Prime Medicine, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
First Horizon Advisors, Inc.
|
SELL
|
- |
-115- 6.34% |
$1.29K - $2.43K
|
1.7K
$5.69K
|
|
|
May 02, 2023
Q1 2023
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-303- 19.34% |
$3.4K - $6.4K
|
1.26K
$4.23K
|
|
|
Apr 24, 2023
Q1 2023
|
Penserra Capital Management LLC
Orinda, CA |
SELL
|
- |
-570- 7.53% |
$6.39K - $12K
|
7K
$23.5K
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-957- 61.86% |
$10.7K - $20.2K
|
590
$1.98K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-9.72K- 98.41% |
$109K - $205K
|
157
$526
|
|
|
May 15, 2023
Q1 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-217K- 9.8% |
$2.43M - $4.57M
|
1.99M
$6.68M
|
|
|
May 15, 2023
Q1 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.47M- 62.01% |
$16.5M - $31.1M
|
904K
$3.03M
|